These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 31302495)
41. miR-198 functions as a tumor suppressor in breast cancer by targeting CUB domain-containing protein 1. Hu Y; Tang Z; Jiang B; Chen J; Fu Z Oncol Lett; 2017 Mar; 13(3):1753-1760. PubMed ID: 28454320 [TBL] [Abstract][Full Text] [Related]
42. Circular RNA hsa_circ_0001982 Promotes Breast Cancer Cell Carcinogenesis Through Decreasing miR-143. Tang YY; Zhao P; Zou TN; Duan JJ; Zhi R; Yang SY; Yang DC; Wang XL DNA Cell Biol; 2017 Nov; 36(11):901-908. PubMed ID: 28933584 [TBL] [Abstract][Full Text] [Related]
43. miR-191/DAB2 axis regulates the tumorigenicity of estrogen receptor-positive breast cancer. Tian X; Zhang Z IUBMB Life; 2018 Jan; 70(1):71-80. PubMed ID: 29247596 [TBL] [Abstract][Full Text] [Related]
44. Knockdown of circDENND4C inhibits glycolysis, migration and invasion by up-regulating miR-200b/c in breast cancer under hypoxia. Ren S; Liu J; Feng Y; Li Z; He L; Li L; Cao X; Wang Z; Zhang Y J Exp Clin Cancer Res; 2019 Sep; 38(1):388. PubMed ID: 31488193 [TBL] [Abstract][Full Text] [Related]
46. Epigenetic Silencing of Ubiquitin Specific Protease 4 by Snail1 Contributes to Macrophage-Dependent Inflammation and Therapeutic Resistance in Lung Cancer. Lai CY; Yeh DW; Lu CH; Liu YL; Chuang YC; Ruan JW; Kao CY; Huang LR; Chuang TH Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31936290 [TBL] [Abstract][Full Text] [Related]
47. USP4 function and multifaceted roles in cancer: a possible and potential therapeutic target. Wang Y; Zhou L; Lu J; Jiang B; Liu C; Guo J Cancer Cell Int; 2020; 20():298. PubMed ID: 32669974 [TBL] [Abstract][Full Text] [Related]
48. The Deubiquitinase USP4 Stabilizes Twist1 Protein to Promote Lung Cancer Cell Stemness. Li F; Hu Q; He T; Xu J; Yi Y; Xie S; Ding L; Fu M; Guo R; Xiao ZJ; Niu M Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32549341 [TBL] [Abstract][Full Text] [Related]
49. circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Sang Y; Chen B; Song X; Li Y; Liang Y; Han D; Zhang N; Zhang H; Liu Y; Chen T; Li C; Wang L; Zhao W; Yang Q Mol Ther; 2021 Dec; 29(12):3525-3527. PubMed ID: 34774125 [No Abstract] [Full Text] [Related]
50. circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer. Liang Y; Song X; Li Y; Su P; Han D; Ma T; Guo R; Chen B; Zhao W; Sang Y; Zhang N; Li X; Zhang H; Liu Y; Duan Y; Wang L; Yang Q Oncogene; 2019 Oct; 38(42):6850-6866. PubMed ID: 31406252 [TBL] [Abstract][Full Text] [Related]
51. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Liang Y; Song X; Li Y; Chen B; Zhao W; Wang L; Zhang H; Liu Y; Han D; Zhang N; Ma T; Wang Y; Ye F; Luo D; Li X; Yang Q Mol Cancer; 2020 May; 19(1):85. PubMed ID: 32384893 [TBL] [Abstract][Full Text] [Related]
52. circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family. Song X; Liang Y; Sang Y; Li Y; Zhang H; Chen B; Du L; Liu Y; Wang L; Zhao W; Ma T; Wang C; Yang Q Mol Ther Nucleic Acids; 2020 Jun; 20():518-533. PubMed ID: 32330870 [TBL] [Abstract][Full Text] [Related]
53. LncRNA LINP1 confers tamoxifen resistance and negatively regulated by ER signaling in breast cancer. Ma T; Liang Y; Li Y; Song X; Zhang N; Li X; Chen B; Zhao W; Wang L; Yang Q Cell Signal; 2020 Apr; 68():109536. PubMed ID: 31927036 [TBL] [Abstract][Full Text] [Related]
54. Circ_0001667 promotes breast cancer cell proliferation and survival via Hippo signal pathway by regulating TAZ. Geng Z; Wang W; Chen H; Mao J; Li Z; Zhou J Cell Biosci; 2019; 9():104. PubMed ID: 31893023 [TBL] [Abstract][Full Text] [Related]
55. Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299/CDK8 Axis. Liu G; Zhang Z; Song Q; Guo Y; Bao P; Shui H Onco Targets Ther; 2020; 13():9497-9511. PubMed ID: 33061434 [TBL] [Abstract][Full Text] [Related]
56. CircUBE2D2 (hsa_circ_0005728) promotes cell proliferation, metastasis and chemoresistance in triple-negative breast cancer by regulating miR-512-3p/CDCA3 axis. Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X; Zhao S Cancer Cell Int; 2020; 20():454. PubMed ID: 32944002 [TBL] [Abstract][Full Text] [Related]
57. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877 [TBL] [Abstract][Full Text] [Related]
58. Circular RNA circABCC4 acts as a ceRNA of miR-154-5p to improve cell viability, migration and invasion of breast cancer cells in vitro. Jiang J; Cheng X Cell Cycle; 2020 Oct; 19(20):2653-2661. PubMed ID: 33023375 [TBL] [Abstract][Full Text] [Related]
59. Circular HER2 RNA positive triple negative breast cancer is sensitive to Pertuzumab. Li J; Ma M; Yang X; Zhang M; Luo J; Zhou H; Huang N; Xiao F; Lai B; Lv W; Zhang N Mol Cancer; 2020 Sep; 19(1):142. PubMed ID: 32917240 [TBL] [Abstract][Full Text] [Related]
60. ZEB1-Mediated Transcriptional Upregulation of circWWC3 Promotes Breast Cancer Progression through Activating Ras Signaling Pathway. Meng L; Liu S; Liu F; Sang M; Ju Y; Fan X; Gu L; Li Z; Geng C; Sang M Mol Ther Nucleic Acids; 2020 Aug; 22():124-137. PubMed ID: 32916598 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]